Geographic patterns of genetic variation, including variation at drug metabolizing enzyme (DME)
loci and drug targets, indicate that geographic structuring of inter-individual variation in …

In IgA nephropathy (IgAN), serum IgA1 with abnormal O-glycosylation deposits in the
glomerular mesangium. The underlying mechanism of this IgA1 O-glycosylation abnormality is …

CKD is associated with a complex state of immune dysfunction characterized by immune
depression, predisposing patients to infections, and immune activation, resulting in …

In IgA nephropathy (IgAN), there is dysregulation of the IgA response to a wide range of
antigens. The dysregulation promotes synthesis of polymeric IgA1 (pIgA1) with physicochemical …

Background Sarcopenia, a degenerative and generalized skeletal muscle disorder involving
the loss of muscle function and mass, is an under‐recognized problem in clinical practice, …

Background The statement that ‘if exercise were a pill it would be one of the most widely
prescribed and cost-effective drugs ever invented’has been used many times, with many slightly …

Kidney transplantation is the gold-standard treatment for many patients with end-stage renal
disease. Renal transplant recipients (RTRs) remain at an increased risk of fatal and non-…

In IgA nephropathy (IgAN), serum IgA1 with abnormal O-glycosylation preferentially deposits
in the glomerular mesangium. The control of O-glycosylation is poorly understood. Among …

Objective: People with nondialysis-dependent chronic kidney disease (CKD) and renal
transplant recipients (RTRs) have compromised physical function and reduced physical activity (…

Background Although evidence shows that patients with end stage renal disease (ESRD)
experience a high symptom burden which impacts on quality of life (QoL), less is known about …